Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
Abstract Vaccination can prevent viral infections via virus-specific T cells, among other mechanisms. A goal of oncolytic virotherapy is replication of oncolytic viruses (OVs) in tumors, so pre-existing T cell immunity against an OV-encoded transgene would seem counterproductive. We developed a trea...
Guardado en:
Autores principales: | Amanda W. K. AuYeung, Robert C. Mould, Ashley A. Stegelmeier, Jacob P. van Vloten, Khalil Karimi, J. Paul Woods, James J. Petrik, Geoffrey A. Wood, Byram W. Bridle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc74d8086b614168938f0bb79a7adef3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
por: Raquel Garijo, et al.
Publicado: (2014) -
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
por: Marie-Claude Bourgeois-Daigneault, et al.
Publicado: (2021) -
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections
por: Robert C. Mould, et al.
Publicado: (2017) -
Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
Publicado: (2021) -
Structure of the vesicular stomatitis virus N⁰-P complex.
por: Cédric Leyrat, et al.
Publicado: (2011)